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Abstract
The aim of this study was to explore potential use of the silk fibroin (SF) as an aqueous coating material for theophylline tablets. We have
examined the film forming and coating properties of heat-treated fibroin, SF solution having different amounts of polyethylene glycol (PEG)
and 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) cross-linked SF. Heat-treated SF material possessed a brittle structure, which
resulted in poor film forming and coating properties. The optimum PEG amount in SF solution was determined as 17% (by weight) for an
acceptable film forming and zero order release profile. EDC cross-linked SF has shown a very good film forming and coating property with a
potential for sustaining the drug release from coated theophylline tablets. Dissolution data for coated theophylline tablets were analyzed
using Ritger and Peppas equation to describe the mechanism of drug release. Drug release from the EDC coated tablets followed zero-order
kinetics. Release rate constants were found to be 0.26, 0.19, 0.16% minK1 for single-coated, double coated, and triple coated tablets,
respectively. These results clearly demonstrated that silk fibroin has high utility as a novel aqueous coating material for controlled release
products.
q 2005 Elsevier B.V. All rights reserved.
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Oral solid dosage forms for sustained drug release has the
major attention amongst all the controlled drug delivery
systems due to its conventional usage. Polymeric film
coatings have been utilized widely for controlled release of
an active substance from pharmaceutical dosage forms
because the coated dosage forms enable the sustained and
precise release of drug with good reproducibility. The
performance of these drug delivery systems is evaluated
primarily in terms of their release kinetics and overall ease
of administration. Methods that release drug with zero order
kinetics (a time-independent rate) for an extended time
period are usually considered optimal. While coating with0939-6411/$ - see front matter q 2005 Elsevier B.V. All rights reserved.
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potential environmental safety and toxicity problems and
economical concerns associated with some organic sol-
vents, the pharmaceutical industry has been exploring
alternatives to organic based tablet coating formulations
[1]. Aqueous polymeric solutions have drawn much
attention to overcome the problems in organic polymeric
solutions. From both academic and industrial point of view
it is essential to improve existing coating materials and
explore the potential of new materials and coating
techniques. Therefore, the pharmaceutical industry expends
a considerable amount of resources to produce oral solid
dosage forms, to replace solvent-based film coatings with
aqueous coating processes [2,3]. Existing aqueous-based
coating materials include cellulosic (e.g. cellulose acetate
dispersion) and acrylic polymers. Examples of commer-
cially available cellulosic aqueous coating systems are
Aquacoatw from FMC Corp., and Sureleasew from Color-
con, Inc. [4,5]. Although both type of polymers have good
film-forming properties resulting in tough protective coat-
ings, there have been several problems confronted such as
unexpected interactions with the active compound, tacki-
ness of the polymeric films causing agglomeration duringEuropean Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 373–381www.elsevier.com/locate/ejpb
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composition or brittleness preventing coherent film for-
mation [1–3]. Similar limitations with existing polymeric
solvent-based pharmaceutical coatings show that there is
still a need to discover new aqueous coating materials
with better film-forming characteristics. Due to these
reasonings, there is an ongoing research for developing
novel coating materials or curing studies on the existing
coating polymers. Zein and starch were investigated as
coating materials and applied to tablets and pellets with
regard to these attempts [6–8].
In this research, potential use of silk fibroin as an aqueous
coating material was investigated. Silk fibroin is an
attractive natural fibrous polymer produced by the species
Bombxy mori [9,10]. It is known that besides material for
clothing, fibroin has been widely applied to cosmetics,
medicine, food and chemical industry [11].
SF, as protein polymer, provides processability in
aqueous solutions to obtain material options with differing
formats. Therefore, aqueous silk solutions represent a good
starting material for the preparation of different kinds of
fibroin-based materials, such as film, gel, powder, and
membranes [11,12]. Recently, several researchers have
investigated SF as one of the promising resources of
biotechnology and biomedical materials due to its unique
properties including good biocompatibility, biodegradabil-
ity, and minimal inflammatory reaction [12–14]. It was
reported that SF had the potential to find applications in the
development of scaffolds in tissue engineering, matrices in
controlled drug delivery systems, and biomaterials such as
artificial skin substitutes and soft contact lenses [12–17].
Besides its promising applications, SF films have poor
mechanical film properties and they are quite hard and
brittle in dry state. However, uniqueness of SF is believed to
arise from the glycilalanil (GlyAla) repeats, which tend to
form the b structure under certain conditions and it can be
easily modified by several treatments such as heating,
immersion in methanol, shearing, blending with natural
polymers such as sodium alginate [18], cellulose [19] and
chitosan [20], or synthetic polymers such as poly(acryl-
amide) [21], poly(vinyl alcohol) [22], poly(ethylene glycol)
[23] and poly(ethylene oxide) [24], or introducing chemical
crosslinking agents [17].
Chemical modifications by using crosslinking reagents
are necessarily applied to find more versatile applications of
biopolymers by the demonstration of improvements. The
commonly used crosslinking agents are aldehydes such as
glutaraldehyde and formaldehyde [25–27] or carbodiimides
such as dicyclohexyl carbodiimide (DDC) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC)
[26–35]. In the literature, carbodiimides, known as non-
cytotoxic and biocompatible crosslinking agents, have been
used to modify the properties of the films made from
proteins and/or polysaccharides [26–35]. Researchers
usually reported that the film forming properties, flexibility
and tensile strengths of the prepared films were improvedafter crosslinking. In this study, a water-soluble carbodii-
mide EDC was used for an aqueous crosslinking reaction of
silk fibroin. There are many studies in literature which had
taken the advantage of water soluble EDC with toxicologi-
cal acceptability such as the crosslinking of collagen/
hyaluronic acid scaffolds with EDC [32,33] and the use of
EDC cross-linked gelatin matrices for the macromolecular
solute release [28]. To our knowledge, there was no report in
the literature on the cross-linking of SF with EDC and
application of SF as a film-forming agent for pharmaceutical
film coatings.
The focus of the current paper was to explore
applications of the silk fibroin as an aqueous coating
material for tablets containing theophylline as the model
drug. In this study, release kinetics of theophylline tablets
coated with three different types of coating materials, heat-
treated fibroin; fibroin-PEG coating; and EDC-cross-linked
fibroin coating, were evaluated.2. Materials and methods
2.1. Materials
The silk of Bombyx mori (domestic silkworm) was
obtained in reeled form from Bursa Institute for Silkworm
Research (Bursa, Turkey). Theophylline (anhydrous) pur-
chased from Sigma Chemical Co. was used as a model drug.
Cellulose tubings (Visking) with molecular cut-off 12,000–
14,000 Da were used for dialysis. Polyethylene glycol
(MWZ4000) was purchased from Merck. Cross-linking
agent used was 1-ethyl-3-(3-dimethyl aminopropyl) carbo-
diimide hydrochloride obtained from Fluka. Na2CO3,
CaCl2, AgNO3 and Ethanol were purchased from Sigma
Chemical Co.
2.2. Preparation of aqueous coating solutions
2.2.1. SF solution
The raw silk fibers of Bomyx mori were processed three
times (40 min each) in 0.5 wt% Na2CO3 solution at 98–
100 8C to remove sericin (degumming), rinsed with
deionized water, and dried at room temperature. The
degummed fibroin (5 g) was dissolved in 100 ml of the
ternary solvent, CaCl2–ethanol–water (mole ratioZ1:2:8),
by stirring at 78 8C for 2 h. The ratio of degummed silk to
ternary solvent was always kept at 1:20 (weight/volume,
respectively). The resulting fibroin solution was filtered
and dialyzed in a cellulose tube against deionized water for
3 days until dialyzate was tested negative for chloride ion
(AgNO3). Then the solution was concentrated to 20% (w/v)
with a rotary evaporator at 37 8C, 60 rpm.
2.2.2. SF/PEG solution
PEG was added to the concentrated fibroin solution in the
beaker at changing ratios to improve the film-forming
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solution with PEG concentration of 12.5, 17, and 25% by
weight, they were dried at 45 8C to cause b sheet
transformation of SF to occur.
2.2.3. SF/EDC solution
A volume of 5 ml fibroin solution 20% (w/v) was mixed
with 5 ml 20 mM EDC in a beaker for 1 h. In this study
N-hydroxysuccinimide (NHS) could be used as an enhancer
to form more stable crosslinking products [30]. However,
even there predicted a slower crosslinking reaction without
NHS, it was preliminarily desired to investigate the
potential of EDC-cross-linked SF films for tablet coating
material and to evaluate the effect of SF-EDC crosslinking
on the release studies.
2.3. Tablet preparation
Theophylline tablets were prepared by compressing
powder form of the drug with the use of hydraulic press
operated at 110 MPa pressure. Stainless steel die with a
diameter of 1.2 cm was used to produce 400 mg drug tablets
having cylindrical shapes.
2.4. Dip-coating
The coating solutions as described in Section 2.2 were
used to coat the surface of theophylline tablets via a dip-
coating method (dip-coater device, Nima Technology Ltd,
England). The coating process places a thin tight coating
over the compressed tablets. The tablets coated with SF
solution and SF/PEG solution were cured at a temperature
of 45 8C for 48 h. The tablets coated with SF/EDC solution
(described in Section 2.4) were dried at room temperature
for 48 h. Double-coated and triple-coated tablets were
prepared by repeating the above coating procedure. The
coated tablets were then stored in closed, light-protected
glass vials until further experimentation.
2.5. Dissolution studies
The in vitro dissolution studies were performed accord-
ing to the United States Pharmacopeia XXIII (USP XXIII)
dissolution methodology using a dissolution device (Caleve
10ST). A volume of 900 ml dissolution medium was placed
in the vessel. Temperature (37 8C) of the dissolution
medium, paddle rotation speed (50 rpm) and dissolution
time (5–6 h) was adjusted by the control unit of the device.
A drug may be expected to remain in stomach for 2–4 h
(gastric emptying time) and in the small intestines for
4–10 h. The pH of the stomach varies from 1 to 3 and in
intestines colon this value is between pH 7 and pH 8. To
simulate the gastro intestinal tract (GIT), the pH of the
dissolution medium was kept at 3 during the first 3.5 h of
dissolution test, then, it was increased to 7.4 and was kept at
that value until the end of the test. In the preparation ofthe dissolution medium, 8.5 v% phosphoric acid was added
to the 900 ml distilled water to reduce pH to the value of 3.
After 3.5 h, the pH of the medium was increased to 7.4 by
adding 5.3 M NaOH to the solution. During dissolution test,
samples were withdrawn from the dissolution medium at
certain times and concentration of theophylline in the
release medium was determined at 272 nm by using a
spectrophotometer (Shimadzu, UV-1601). Each dissolution
test was conducted on three tablets and the mean of the
results was calculated.
The release data of drug from coated tablets was fitted by
using Eq. (1) [36] in order to propose the possible release
mechanism.
Mt
MN
Z Ktn (1)
Where Mt corresponds to the amount of drug released at
time t; MN is the total amount of drug that must be released
at infinite time; K is a release constant and is related to the
structural and geometric properties of the dosage form; n is
the release exponent indicating the type of drug release
mechanism. This equation has been used frequently in the
literature, due to its utility in describing the relative
importance of Fickian (nZ0.5) and zero-order (nZ1)
mechanism in drug diffusion. In zero-order kinetics, the
release rate remains constant until the entire active
ingredient has been delivered. The term zero-order means
time-independent rate and so as being independent of
quantity of drug remaining. The t50 is the time at which 50%
of the drug was released from the tablet.2.6. Characterization
The morphology of the surfaces of the coated tablets was
examined by scanning electron microscopy (SEM) (Philips,
XL-30S FG). Cross-sectional SEM images of the coated
tablets were used to determine the overall coating thickness.
FTIR and XRD analyses were performed for EDC cross-
linked SF film coatings to confirm the structural changes.3. Results and discussion3.1. Coating with heat-treated SF
Processing conditions such as solution concentration,
solution temperature, drying temperature, drying time, the
presence of electric field, pH, the presence of certain
enzymes and type of solvent can be used to control the
molecular conformation of the resulting SF membrane [37].
Silk fibroin films prepared by casting the aqueous protein
solution and drying at 25 8C are soluble in water [38]. Such
films have a micro phase-separated structure consisting of
crystal and amorphous regions. It is found that higher
processing temperature (45 8C) leads the amorphous random
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Fig. 1. Release profile of the theophylline tablet coated with heat-treated
SF.
O. Bayraktar et al. / European Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 373–381376coil structure in the membranes to convert to b-pleated
structure [38]. This structure produces morphology with
aggregated fibrils. The starting solution concentration and
casting temperature are of critical importance for the
structure of the fabricated films [39]. Insolubilization of
fibroin coating around the tablet is required to achieve
sustained release of theophylline. After coating the prepared
theophylline tablets using SF solution the tablets were dried
at 45 8C in a static oven in order to convert the structure from
random coil to b-sheet form. The conformational change in
SF structure was investigated earlier in the literature [37–39].
By achieving b-sheet transformation of the silk fibroin,
insoluble membranes could be obtained.Fig. 2. SEM micrographs of theophylline tablTo investigate the drug release kinetics, dissolution tests
of the tablets coated with heat-treated silk fibroin were
performed. The release profiles of the prepared tablets have
been interpreted according to the target profile suggested by
Parab et al. [40]. The release profiles of uncoated and heat-
treated silk fibroin coated theophylline tablets and the target
release profile are shown in Fig. 1. Dissolution data of
uncoated theophylline tablet showed 100% drug release at
the end of 210 min. As seen from Fig. 1, release profile was
far from the desired target profile. To achieve sustained
release tablets were coated with heat-treated silk fibroin. For
this case drug release was sustained to a certain extent up to
100 min. Only 34% of the theophylline released showed a
linear release pattern, after that an anomalous or diffusion
release profile was observed. This result was due to partial
removal of SF coating around the tablet at the 100 min of
the dissolution test. The remaining insoluble fibroin coating
has slowed the release, but this was not good enough
to obtain a release profile similar to the target linear profile.
The K, n, values and regression coefficients of the curves for
the tablet coated with heat-treated silk fibroin were
evaluated for two regions. In the first region, which is
up to 34% drug release, the diffusion occurred through
the channels of the coating and drug release
mechanism could be described by zero order kinetics
(KZ0.34% minK1, nZ0.97, R2Z0.98). In the second
region after the coating around the tablet was partially
peeled off, the release occurred with relatively less
diffusional barrier. Therefore, release rate was enhancedets coated with heat-treated silk fibroin.
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Fig. 3. Influence of PEG concentration on the release profile of
theophylline.
Fig. 4. Model for the formation of SF sheet planes including ductile PEG
chains.
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150 min (Fig. 1).
Examination of the tablet coating by scanning electron
microscopy (SEM) revealed poor coating comprised of
numerous surface defects and cracks in the film structure as
shown in Fig. 2a and b. As shown in Fig. 2c and d the heat-
treated fibrous coating also have a surface with varying
porosity and channels where diffusion mechanism occurred
within these channels. Since the heat-treated silk fibroin
coating possessed a brittle structure, which probably cause
poor film forming, and poor interaction between SF coating
and theophylline particles (Fig. 2b), fibroin films in dry state
become unsuitable for practical use. In order to improve
film-making property of SF, PEG was used as a plasticizer
in the SF coating solutions.
3.2. Coating with SF/PEG solution
Heat-treated fibroin coating on the surface of tablets
exhibited severe brittleness and cracking. This demon-
strated the need for a plasticizer. PEG was found to be
compatible with the fibroin solution since both are water
soluble. SF-PEG blend was used as a tablet coating solution.
The kinetics of drug release was investigated, after coating
theophylline tablets with the SF solution having different
amount of PEG. The release profiles obtained can be seen in
Fig. 3. While the uncoated tablet dissolved almost
completely at the end of 210 min, the tablets coated with
the SF solution having 12.5 and 25% PEG dissolved
completely at the end of 300 min. The tablet coated with SF
solution containing 17% PEG required a longer release time
(t50Z245 min for 50% drug release) and release rate was
slower than the others. The tablets coated with SF solution
containing 12.5% (KZ0.45% minK1; nZ0.98), 17% (KZ
0.20% minK1; nZ0.98) and 25% (KZ0.33% minK1; nZ1)
PEG presented zero order release mechanism with the
regression coefficients (R2) values of 0.98, 0.98, 099,
respectively. The best release profile was observed with
the tablet coated with SF solution containing 17% PEG.
After blending PEG with aqueous fibroin solution, PEGchains may form a PEG-rich phase separated from the SF
domains. The heat treatment initiates the formation of b-
sheets. PEG chains can be captured between b-sheet planes
without hindering the formation of b-sheet planes. The
improved mechanical properties of SF-PEG coating could
be explained by supposing that the sliding between SF
sheets planes due to the ductile PEG-rich phases (Fig. 4).
Above certain amount of PEG concentration in the SF
coating solution (For this case, 17% PEG), the formation of
b-sheet planes could be hindered and the layered structure
of SF-PEG film, which was also speculated by other
researchers [23], cannot be formed. Therefore the drug
might diffuse more rapidly above critical PEG ratios. The
incorporation of plasticizers primarily aims at reducing the
brittleness of the polymeric films [41].3.3. Coating with EDC cross-linked SF
The aim of this part was to use EDC cross-linked fibroin
as a coating material for sustained release of theophylline.
Carbodiimides are zero-length cross-linkers and affect
direct coupling between carboxylates (–COOH) and pri-
mary amines (–NH2) to form stable amide bonds [30]. As
mentioned in Section 3.1, the heat-treated fibroin tablet
coating had poor mechanical film properties and they were
quite brittle. It was observed that cross-linking of SF with
EDC made the membrane flexible [42,43].
The dissolution tests were performed for the tablets
coated with EDC cross-linked silk fibroin. Fig. 5 shows
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double-coated, and triple-coated tablets. Multiple coating
allowed us to change the thickness of the coating on the
tablets in order to observe the effect of coating thickness on
the release profile of theophylline. The release profiles of the
tablets coated with EDC cross-linked fibroin were compared
with that of the uncoated theophylline tablet and target
release profile as seen in Fig. 5. As shown in this figure
sustained release profiles were achieved for three samples
coated with EDC cross-linked fibroin solution since the
EDC cross-linked SF membrane prevented rapid diffusion
of the drug. It was observed that resistance to transport of
drug increased with increasing the length of diffusion path,
in other words, increasing the number of coatings. The
release rate constants of coated tablets were much smaller
than uncoated tablets (KZ0.60% minK1, R2Z0.99).
Release rate constants were found to be 0.26, 0.19,
0.16% minK1 with the regression coefficient (R2) value of
0.99 for single-coated, double coated, triple coated tablets,
respectively. The release rate of theophylline from coated
tablets was significantly decreased due to more barrier
hindrance by thicker coating materials. The thickness of the
film influences the rate of dissolution of the drug. For this
reason thickness is an important factor. As shown in Fig. 5,
the double-coated tablet is more similar to the target release
profile than the others. When the tablets coated with cross-
linked silk fibroin solution, it not only reached a sustainedFig. 6. SEM micrographs of theophylline tabrelease profile but also followed a zero order drug release
mechanism with n values close to 1.
SEM micrographs of the EDC cross-linked fibroin coated
tablet are shown in Fig. 6. These micrographs were obtained
to observe the morphology of the tablet coating and to
determine the coating thickness. SEM micrographs of the
double-coated tablets at different magnifications were
obtained in order to observe morphology of the cross-
section of this sample. Porous structure of the coating can be
seen in Fig. 6. The coating thicknesses were measured at
various parts of the each tablet’s cross-section and the
average values of them were taken. The average coating
thickness was measured as 26, 57, 83 mm for single coated,
double coated and triple coated tablets, respectively. As
expected the release rate was inversely proportional to the
thickness of the coatings. The 50% of drug was released
from uncoated tablet within 83 min (t50Z83 min). t50 values
were determined as 185, 250, and 306 min for single coated,
double coated and triple coated tablets, respectively. Since
resistance to transport of drug increased with increasing the
length of diffusion path, the decrease in release rate with
increasing number of coating was an expected result.
FT-IR spectroscopy was performed and IR spectra of the
regenerated SF films are shown in Fig. 7. The structural
changes caused by the EDC cross-linking can be revealed by
analyzing the amide I, II, III bands in IR spectroscopy. It is
well established for fibroin and other proteins that the peaklets coated with EDC crosslinked SF.
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Fig. 7. FT-IR spectra of SF film (A) and EDC crosslinked SF film (B).
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secondary structure [44]. The vibrational transition bands of
CaO stretching (1655 cmK1, amide I), N–H de-formation
and C–N stretching (1540 cmK1, amide II), and C–N
stretching and N–H deformation (1250 cmK1, amide III)
are seen in the figure. Fig. 7 shows the FT-IR spectra of a
fibroin film (Fig. 7a), and the film after cross-linking with
EDC (Fig. 7b). The fibroin film showed strong absorption
bands at 1655 (amide I), 1540 (amide II), and 1235 cmK1
(amide III), attributed to the random coil conformation
(Fig. 7a). In Fig. 7b, spectral changes induced by the EDC
cross-linking are recognized. The spectrum before the cross-
linking with EDC is apparently ascribable to the random-coil
structure. With the EDC cross-linking, the most obvious
feature of the b-sheet structure in IR spectroscopy is the
strong absorption band at 1250 cmK1 in the amide III band
[44]. Formation of amide bond between carboxylic acid
and amino groups of gelatin after cross-linking with EDC was
reported in the literature [26]. This band was clearly detected
for the amide III band of the film after EDC cross-linking.
This result suggested that the conformational change of SF
occurred from the random coil to the b-sheet structure due to
the cross-linking with EDC. The spectral changes agree well
with a result reported previously [44].XRD method has been mainly used to study crystalline
structure, which affects various properties in solid state. The
X-ray diffraction patterns of SF film from aqueous solution
and EDC cross-linked SF film are shown in Fig. 8. The X-
ray diffraction pattern for the SF film showed a broad peak
with a maximum at 2qZ208.(Fig. 8a), corresponding to the
typical characteristics diffraction pattern of amorphous silk
fibroin. According to the Bragg’s equation, 2 d sin qZnl,
where n is an order of the reflection (assigned to 1), l is the
wavelength of Cu Ka radiation (Z1.542 A˚), and q is an
incident angle, the distance (d) between the repeating units
was 4.44 A˚. This pattern was quite similar to the results
reported in the literature [22]. The EDC cross-linked SF film
showed sharp diffraction peaks at 2qZ14.3, 17.0, and 25.68,
corresponding to the crystalline spacing of 6.19, 5.22, and
3.48 A˚, respectively (Fig. 8b). The insolubility property and
the crystal structure finding are consistent with the literature
[10,37–39]. It was, thus, confirmed by both FTIR spectra
and X-ray diffraction that the secondary structure of fibroin
molecules changed to b-sheets.4. Conclusions
Silk fibroin can be considered as a potential aqueous film
coating agent to be used for solid pharmaceuticals. Silk
fibroin film-coated tablets could be easily prepared without
any sophisticate equipment. Hence, this would also be better
than the conventional organic-based coating technique,
which caused a polluted environment and was toxic to
humans. The EDC cross-linked silk fibroin exhibited
O. Bayraktar et al. / European Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 373–381380prospectively suitable properties for zero order release of
the drug. The investigated SF coating material therefore
merits further study in the design of film-coated sustained
drug delivery devices.Acknowledgements
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